Global Barrett’s Esophagus Market Analysis 2024 – Estimated Market Size And Key Drivers|F Hoffmann-La Roche Ltd., Sanofi SA, AstraZeneca PLC, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Medtronic PLC.

The Barrett’s Esophagus Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Barrett’s Esophagus Market:
https://www.thebusinessresearchcompany.com/report/barretts-esophagus-global-market-report

According to The Business Research Company’s Barrett’s Esophagus Global Market Report 2024, The barrett’s esophagus market size has grown strongly in recent years. It will grow from $5.98 billion in 2023 to $6.33 billion in 2024 at a compound annual growth rate (CAGR) of 5.9%. The growth in the historic period can be attributed to increasing prevalence of gastroesophageal reflux disease (gerd), aging population, increased awareness and screening programs, obesity epidemic, tobacco and alcohol consumption.

The barrett’s esophagus market size is expected to see strong growth in the next few years. It will grow to $8.1 billion in 2028 at a compound annual growth rate (CAGR) of 6.3%. The growth in the forecast period can be attributed to genetic and molecular research, personalized medicine approaches, increased focus on early detection, rising global healthcare expenditure, integration of artificial intelligence (ai). Major trends in the forecast period include collaborative research initiatives, innovations in endoscopic technologies, advancements in diagnostic technologies, integration of patient registries, lifestyle modification programs.

Increased chances of esophageal cancer are expected to propel the growth of barrett esophagus market going forward. Esophageal cancer refers to a type of cancer that affects the esophagus, a long, hollow tube that connects the throat to the stomach. The rise in esophageal cancer occurs in patients with Barrett’s esophagus with dysplasia. However, the chance of developing esophageal cancer is higher in people with high-grade dysplasia in Barrett’s esophagus. For instance, in 2023, according to the American Cancer Society, a US-based cancer-fighting organization that provides patient support, research, and advocacy for cancer care, esophageal cancer will affect an estimated 21,560 people in 2023, compared to 20,640 people affected in 2022. Therefore, an increase in the chance of esophageal cancer is driving the growth of barrett esophagus market.

Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=11990&type=smp

The barrett’s esophagus market covered in this report is segmented –

1) By Type: No Dysplasia, Low-Grade Dysplasia, High Grade Dysplasia, Other Types
2) By Treatment: Medication, Endoscopic Therapy, Surgery, Other Treatments
3) By Route Of Administration: Oral, Parenteral, Rectal, Other Routes Of Administration
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels

Product innovations are the key trends gaining popularity in barrett esophagus market. Major companies operating in barrett esophagus market are focusing on developing new innovative products to sustain their position in the market. For instance, For instance, in October 2022, Phagenesis Ltd., a UK-based dysphagia care company, launched the Phagenyx neurostimulation system based on pharyngeal electrical stimulation technology. The phagenyx neurostimulation system is a new rehabilitation treatment for dysphagia after stroke that improves swallowing performance in individuals with stroke-related neurogenic dysphagia (ND). It operates by directly stimulating the pharynx with intraluminal catheters placed through the nose. Furthermore, PES technology has the potential to improve the quality of life of people with dysphagia, lower healthcare expenses, and expand its applicability to a larger variety of dysphagia patients.

The barrett’s esophagus market report table of contents includes:

1. Executive Summary
2. Barrett’s Esophagus Market Characteristics
3. Barrett’s Esophagus Market Trends And Strategies
4.Barrett’s Esophagus  market analysis
5. Barrett’s Esophagus Market Size And Growth
6. Barrett’s Esophagus Segmentation
7. Barrett’s Esophagus Regional And Country Analysis
.
.
.
27.Barrett’s Esophagus  Competitive Landscape And Company Profiles
28.Barrett’s Esophagus  Key Mergers And Acquisitions
29.Barrett’s Esophagus  Future Outlook and Potential Analysis

TOP MAJOR PLAYERS:

• F Hoffmann-La Roche Ltd.
• Sanofi SA
• AstraZeneca PLC
• GlaxoSmithKline PLC
• Takeda Pharmaceutical Company Limited
• Medtronic PLC.

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293

Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model